Information about Attana's presentation at Erik Penser Bank's Company Day on Mars 10 at 13.40
On Thursday, March 10 at 13.40, Attana will participate in Erik Penser Bank’s Company Day. Teodor Aastrup, CEO of Attana, will hold a company presentation followed by a short Q&A session.
The 15-minute presentation will primarily focus on Attanas latest track record and proven value cration within drug development and the company’s strengthened patent portfolio including two new patent applications.
- Attana in short
- Life Science
- Updated track record
- Strengthened patent portfolio
The event, taking place at Erik Penser Bank, will also be live streamed and can be viewed on Erik Penser Bank’s Youtube channel.
When: March 10 at 13.40
Where: Erik Penser Bank and digital accessed through this link
For more information, please contact:
Teodor Aastrup, CEO
+46 (0)8 674 57 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.
Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact firstname.lastname@example.org